Skip to main content
Log in

GP IIb/IIIa Antagonists

Summary and Table

  • Section 1: GP IIb/IIIa Antagonist in Cardiology
  • Adis Profile Summary
  • Published:
Drugs in R & D Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Foster RH, Wiseman LR. Abciximab: an updated review of its use in ischaemic heart disease. Drugs 1998 Oct; 56 (4): 629–65

    Article  PubMed  CAS  Google Scholar 

  2. McClellan KJ, Goa KL. Tirofiban: a review of its use in acute coronary syndromes. Drugs 1998 Dec; 56 (6): 1067–80

    Article  PubMed  CAS  Google Scholar 

  3. Goa KL, Noble S. Eptifibatide: a review of its use in patients with acute coronary syndromes and/or undergoing percutaneous coronary intervention. Drugs 1999 Mar; 57 (3): 439–62

    Article  PubMed  CAS  Google Scholar 

  4. Dooley M, Goa KL. Lamifiban. Drugs 1999 Feb; 57 (2): 215–21

    Article  PubMed  CAS  Google Scholar 

  5. Dooley M, Goa KL. Sibrafiban. Drugs 1999 Feb; 57 (2): 225–30

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Coleman, S.G., Duff, R. GP IIb/IIIa Antagonists. Drugs R&D 1, 371–373 (1999). https://doi.org/10.2165/00126839-199901050-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00126839-199901050-00002

Keywords

Navigation